Avaliação multifactorial da qualidade de vida em doentes gastrectomizados por cancro gástrico. estudo piloto de métodos de avaliação

P. Costa¹, J. Carraca², A. Sofia Brito³, N. Figueiredo⁴, P. Lages⁴

 

 

Resumo

Estudámos um grupo de 18 doentes com carcinoma do estômago com sobrevivência prolongada após terapêutica cirúrgica. Foi realizada uma avaliação inicial da qualidade de vida (QV) através de três testes: um inquérito sintomático, o teste de FLIC (Functional living index – cancer) e o índice de Korenaga. Esta avaliação foi complementada com a determinação de parâmetros nutricionais, hematológicos e do metabolismo ósseo. Cinco anos após este estudo foi possível repetir a avaliação da QV em 9 destes 18 doentes.

Globalmente a avaliação da QV mostrou índices bons ou muito bons nos três inquéritos quer na avaliação inicial quer na efectuada cinco anos depois. Todos os testes de avaliação de QV se correlacionaram entre si. Também se encontraram correlações significativas entre alguns testes de QV e o índice de massa corporal, valores de albumina e valor de hemoglobina.

A aplicação destes testes, envolvendo um largo espectro de indicadores de QV, em doentes submetidos a três tipos diferentes de intervenção cirúrgica, mostrou uma boa capacidade discriminativa. Pensamos que esta bateria de testes está adaptada, nos seus instrumentos, para ser utilizada no nosso protocolo de avaliação da QV.

 

 

 

Summary

A group of 18 patients with long survival after surgery for gastric cancer were evaluated for quality of life (QL). The initial assessment of QL used three separate tests: a symptom inquiry, the FLIC test (Functional living index – cancer) and the Korenaga index. Nutritional status, haematological and bone metabolism were also assessed. Five years later we were able to repeat the QL tests on nine of the eighteen patients.

The indexes of the three tests were generally good or very good, either in the first assessment or in the later. All three tests showed statistical correlation among them. Significant correlations were also evident between some tests and biological markers such as haemoglobin and albumin as well as the body mass index.

The use of these tests, displaying a wide spectrum of QL indicators, was able to discriminate patients with different surgical operations.

We believe this group of tests is well adapted to study our patient population and can be very useful in the systematic follow-up of patients operated on for gastric cancer.

 

 

Texto Completo disponível apenas em PDF

Full text only available in PDF format

 

 

Bibliografia

 

1. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Cooperative Group. Br J Cancer 1999; 79: 1522-30.        [ Links ]

2. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended limph-node dissection for gastric cancer. Gastric Dutch Cancer Group. N Engl J Med 1999; 340: 908-14.

3. Siewert JR, Bottcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer: 10 year results of the German Gastric Cancer Group Study. Ann Surg 1998; 228: 449-61.

4. Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: the functional living index-cancer: development and validation. J Clin Oncol 1984; 2: 472-483.

5. Korenaga D, Orita H, Okuyama T, et al. Quality of life after gastrectomy in patients with carcinoma of the stomach. Br J Surg 1992; 79: 974-5.

6. Ingenbleek Y, Carpentier YA. Prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr es 1985; 55: 91.

7. Eyre DR. Bone biomarkers as tools in osteoporosis management. Spine 1997; 22: 17S-24S.

8. Blazeby JM, Conroy T, Bottomley A, et al. Clinical and Psychometric validation of a questionnaire module, the EORTC QLQSTO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer 2004; 40: 2260-68.

9. Andersson N, Surve VV, Lehto-Axtelius D, Ohlsson C, Hakanson R, Andersson K, Ryberg B. Drug-induced prevention of gastrectomy- and ovariectomy-induced osteopaenia in the young female rat. J Endocrinol. 2002; 175): 695-703.

10. Klinge B, Lehto-Axtelius D, Akerman M, Hakanson R. Structure of calvaria after gastrectomy. An experimental study in the rat. Scand J Gastroenterol. 1995; 30: 952-7.

11. Axelson J, Persson P, Gagnemo-Persson R, Hakanson R. Importance of the stomach in maintaining calcium homoeostasis n the rat. Gut. 1991; 32): 1298-302.

12. Persson P, Gagnemo-Persson R, Chen D, Axelson J, Nylander AG, Johnell O, Hakanson R. Gastrectomy causes bone loss in the rat: is lack of gastric acid responsible? Scand J Gastroenterol. 1993; 28:301-6.

13. Mochiki E, Kamiyama Y, Aihara R, et al. Postoperative functional evaluation of jejunal interposition with or without a pouch after total gastrectomy for gastric cancer. Am J Surg 2004; 187:728-35.

14. Lehnert T, Buhl K. Techniques of reconstruction after total gastrectomy for cancer. Br J Sur 2004; 91: 528-39.

 

 

 

(1) Hospital Santa Maria, Lisboa; FACS, FRCS

(2) Serviço de Cirurgia 3, Hospital de Santa Maria, Lisboa, Portugal.

(3) Serviço de Psiquiatria, Hospital de Santa Maria, Lisboa, Portugal.

(4) Interno de Cirurgia Serviço de Cirurgia 3, Hospital de Santa Maria, Portugal.

e-mail: paulo.mcosta@hsm.min-saude.pt

 

Recebido para publicação 05/05/2006

Aceite para publicação 17/05/2006